null

Narsoplimab (Anti-MASP2) Biosimilar Antibody

SKU:
HDBS0145
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
MASP2
Reactivity:
Human
Host Species:
Chimeric Humanized
Isotype:
IgG4
€373
Frequently bought together:

Description

system_update_altDatasheet

Narsoplimab (Anti-MASP2) Biosimilar Antibody (HDBS0145)

The Narsoplimab Biosimilar Anti-MASP2 Antibody is a cutting-edge research tool designed for studying the role of MASP2 in the lectin pathway of the complement system. This antibody, produced using innovative biosimilar technology, specifically targets MASP2, a key enzyme involved in activating the complement cascade.MASP2 is critical for the initiation of the lectin pathway, which plays a vital role in innate immunity and the clearance of pathogens. Dysregulation of this pathway has been implicated in various diseases, including autoimmune disorders, inflammatory conditions, and infectious diseases.

By targeting MASP2, researchers can gain insights into the mechanisms underlying these diseases and identify potential therapeutic interventions.This high-quality antibody is validated for use in a variety of research applications, including Western blotting and immunohistochemistry. Its specificity and sensitivity allow for accurate detection and analysis of MASP2 in different experimental settings, making it an invaluable tool for researchers studying the complement system and its implications in health and disease.